External Quality Assessment of Transfusion-transmissible Infections Testing
Journal Title: International Blood Research & Reviews - Year 2017, Vol 7, Issue 4
Abstract
Aims: To assess the overall performance of the transfusion-transmissible infection testing laboratory through the evaluation of the results obtained from the participation in a blood proficiency testing study (B-PTS). Study Design: The B-PTS study was designed, organized and conducted by European directorate for the quality of medicines (EDQM). We were requested to test the B-PTS samples and to report the results on the online result data sheet. Place and Duration of Study: The 3 blood testing laboratories of the Institute of transfusion medicine in Macedonia; July 2017. Methodology: Each set of B-PTS-samples contained 4 panels: Anti-HCV (032), anti-HIV/p24 (033), anti-Treponema (034) and HBsAg panel (035). The samples were subjected to serological testing with two assays: Enzyme immunoassay with Enzygnost system, Siemens using BEP2000 and chemiluminescent microparticle immunoassay with Architect system, Abbott using Architect i2000. Results: The laboratories were classified as “satisfactory” for B-PTS032 and B-PTS034. For B-PTS033 the classification was “non evaluable” because the results were not properly submitted. The B-PTS035 results were classified as “unsatisfactory” because two laboratories reported the reactive sample number 3 as “Not Reactive” with the Enzygnost assay and one laboratory reported it as “Not Reactive” with the Architect assay. The single observed non-conformity was that the S/Co (1.22) of the positive control for the Architect HBsAg assay was out of rang (1.65-4.96) for the corresponding reagent lot. Conclusion: The participation in a B-PTS study provides an objective and independent evaluation of the overall performance of the laboratory. The management of the non-satisfactory PTS results should be documented and performed in a controlled manner. Appropriate corrective and preventive measures should be taken in order non-conformities not to repeat.
Authors and Affiliations
Tatjana Makarovska Bojadzieva, Lolita Mitevska, Jasmina Trojacanec
Keywords
Related Articles
- EP ID EP306781
- DOI 10.9734/IBRR/2017/38371
- Views 107
- Downloads 0
Cytomegalovirus-induced Pure Red Cell Aplasia Successfully Treated with Ganciclovir: A Case Report
Background: Acquired pure red cell aplasia (PRCA) is a rare disease characterized by anemia, severe reticulocytopenia and absent to low bone marrow erythroid precursor cells. There are well-described associations of this...
Outpatient Management of Acute Leukemia: A Systematic Review and Meta Analysis
Background/Aim: Outpatient chemotherapy administration for solid tumors is a commonly accepted practice given its advantage of easy and safe drug administration, ability to value the patient’s wish to avoid hospitalizati...
Preliminary Report on the Frequency of Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor-gamma Gene in Egyptian β-Thalassemia Major Patients
Osteoporosis represents an important cause of morbidity in adult thalassemic patients. Peroxisome proliferator-activated receptor-γ (PPAR γ) is a master transcriptional regulator involved in expression of probably hundre...
Iron Overload, Chelation Therapy and Survival in Lower-Risk Myelodysplastic Syndromes: State of the Evidence
Myelodysplastic syndromes (MDS) are clonal stem cell disorders that primarily affect older persons and are associated with peripheral blood cytopenias, increased risk of conversion to acute myeloid leukemia and shortened...
In vivo Studies on the Possible Haematological Changes in Rats Administered Hibiscus sabdariffa Aqueous Extract
The aqueous extract of Hibiscus sabdariffa leaves is popularly consumed in the form of “Zobo” drink in Nigeria and it is assumed to have haematological benefits. The present study was conducted to evaluate the effects of...